Researchers boost hypertension treatment using unconventional approach Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.…
Target six high-risk drugs during medication reviews, say researchers Researchers have identified six high-risk medicines or combinations of high-risk medicines that should be targeted in medicines reviews to reduce iatrogenic disease in older people.…
Heart risks with newer hepatitis C drugs and amiodarone The EMA has warned against the use of antiarrhythmic amiodarone in combination with newer hepatitis C infection treatments after reports of heart problems.…
Metformin plays a role in lowering blood cholesterol Metformin, one of the most widely used medications for type 2 diabetes, has a positive effect on LDL cholesterol as well as blood glucose, according to research published in Diabetes Care.…
Preclinical randomised controlled trials could tackle high attrition rates in drug development Researchers have come up with a potential solution to the problem of experimental drugs failing in clinical trials, despite promising results from preclinical, animal studies.…
MHRA review concludes alteplase is safe for treating acute ischaemic stroke The Medicines and Healthcare products Regulatory Agency has backed the continued use of the thrombolytic drug alteplase for up to 4.5 hours after the onset of symptoms of acute ischaemic stroke.…
First PCSK9 inhibitors approved in Europe and United States The US Food and Drug Administration has approved alirocumab (Praluent), days after evolocumab (Repatha) became the first PCSK9 inhibitor to be approved in the world.…
More people should be taking statins for primary prevention, US study suggests US guidelines that set the threshold for starting statin therapy at a lower level than the threshold recommended by the National Institute for Health and Care Excellence in England are cost effective, say researchers.…
Orthostatic hypotension drug midodrine to be launched Midodrine hydrochloride (Bramox) is due to be launched in the UK on 29 July 2015 after obtaining marketing authorisation from the medicines safety regulator, its manufacturer has announced.…
Antihypertensive therapy may lower Alzheimer’s risk Researchers found taking antihypertensive medication may be associated with a decreased risk of Alzheimer’s disease.…